In the evolving landscape of podiatric medicine, Low-Level Laser Therapy (LLLT) emerges as a beacon of innovation, offering a blend of efficacy and safety in the treatment of various foot conditions. LLLT, with its non-invasive approach and minimal side effects, stands out as a promising addition to podiatric care, especially in managing onychomycosis. Among the forefront of LLLT technologies is the Lunula Laser®, a device that has revolutionized the approach to treating toenail fungus with its patented technology.
Low-Level Laser Therapy (LLLT) represents a light-based technology that stimulates cellular processes and promotes tissue healing without the thermal effect of higher-power lasers. Specifically, in podiatry, LLLT like the Lunula Laser® targets toenail fungus by stimulating new, healthy nail growth and diminishing fungal infection, offering a novel approach to managing onychomycosis.
The Lunula Laser® distinguishes itself as a product of choice for podiatrists looking to incorporate LLLT into their practice. This FDA-cleared device delivers a non-thermal, pain-free therapy using red and violet laser light to target fungal infections and stimulate healing, addressing the condition effectively without discomfort to patients. Key features of the Lunula Laser® include:
Setting up the Lunula Laser® in a podiatric practice requires minimal adjustments, thanks to its user-friendly design and quick treatment protocol. This allows podiatrists to enhance their practice’s service offerings efficiently.
Identifying candidates suitable for LLLT with the Lunula Laser® involves a comprehensive assessment to diagnose onychomycosis and evaluate the extent of the fungal infection. Through this initial evaluation, podiatrists can tailor treatment plans to the specific needs of each patient, ensuring optimal outcomes.
The Lunula Laser® shines in its versatility and efficacy in treating toenail fungus across various stages. Treatment protocols typically involve four 12-minute sessions, with the exact regimen adjusted based on the severity of the condition and patient response.
Treatment with the Lunula Laser® is straightforward. The affected area is exposed to the laser light for 12 minutes, stimulating the healing process and targeting the fungus. Adjustments to treatment may be necessary based on patient progress, with assessments conducted at regular intervals to monitor the response.
An integral component of LLLT treatment success is patient education and diligent follow-up. Educating patients about the Lunula Laser® treatment process and expected outcomes helps set realistic expectations. Regular follow-up appointments are crucial to monitor progress and make any necessary adjustments to the treatment plan.
The integration of Low-Level Laser Therapy, particularly through the revolutionary Lunula Laser®, into podiatric practice represents a significant step forward in the treatment of onychomycosis. Its non-invasive nature, coupled with its efficacy and safety profile, makes it an attractive treatment option for both podiatrists and patients.
Dr. Jordan Steinberg, DPM, shares his experience with the Lunula Laser®, “I have been using the Lunula laser in my office for approximately nine months. I have used many other toenail lasers in the past and I would have to say that this laser is the most effective and easiest laser for the patient and the doctor. The patients love the technology and love the fact that they are not feeling any discomfort when the laser is in use.”
This testament, along with the technology’s innovative approach to treating onychomycosis, underscores the Lunula Laser®’s position as a pivotal tool in modern podiatric care, promising enhanced patient satisfaction and significant improvements in foot health.
In the world of veterinary medicine, advancements come in many forms, but the quiet revolution of low-level laser therapy (LLLT) has been as intriguing as it is effective. Often flying under the radar due to its non-invasive nature, LLLT has been transforming the way veterinarians treat a range of conditions in animals. Here is your comprehensive guide to what veterinary laser therapy is, how it’s helping animals, and why it’s a beacon of innovation in the veterinary world.
Low-level laser therapy, or photobiomodulation, is a light-based treatment for a variety of conditions in both human and animal patients. It is known for its ability to stimulate healing, reduce pain and inflammation, and increase mobility. The laser beams used in LLLT are of a lower intensity compared to those used for surgical procedures, making them a safe and effective form of medical treatment for animals who may not respond well to traditional therapies.
The application of LLLT involves exposing tissue to low levels of light from red and near-infrared lasers, commonly referred to as cold lasers. When these photons of light penetrate the areas requiring treatment, they interact with the cells in the body, sparking a cascade of beneficial biological reactions. These responses typically include:
In the veterinary setting, these outcomes translate into a more rapid and comfortable recovery for animals, making LLLT an invaluable therapeutic tool in the hands of skilled professionals.
The scope of conditions that can be positively affected by veterinary laser therapy is quite broad, with benefits extending from post-operative care to chronic pain management. This diversity of applications makes LLLT not only versatile but also an integral part of providing comprehensive care for the animal patients.
Non-healing wounds can be a significant challenge in veterinary medicine, but LLLT has shown exceptional promise in promoting healing. Whether it’s a surgical incision, an ulcer, a pressure sore, or a traumatic wound, the application of laser therapy can significantly accelerate the repair process of wounds in animals.
One of the most compelling aspects of LLLT is its ability to alleviate pain in a manner that is gentle and non-invasive. It’s a drug-free approach to pain relief, which is especially appealing for both veterinarians and pet owners looking for alternative options that don’t carry the risks or side-effects associated with many pharmaceuticals.
In animals recovering from surgery or injury, regaining mobility is a key goal. LLLT can support physical rehabilitation by reducing pain and inflammation, allowing animals to comfortably participate in therapeutic exercises and activities that restore their normal function.
LLLT has also demonstrated antibacterial and antifungal properties, which can be invaluable in managing infections. This can be particularly beneficial in chronic cases where conventional treatments may be less effective or for animals that cannot tolerate antibiotics.
The benefits of LLLT aren’t just skin-deep. Laser therapy aids in bone healing, which can be especially important for animals with fractures or orthopedic conditions. It also has a neuroprotective effect, making it an option for managing nerve-related issues and promoting neurological recovery post-injury or surgery.
The diversity of the animal kingdom presents a rich tapestry of anatomical and physiological differences. As such, it’s crucial to tailor LLLT treatments to the specific needs of different species. Whether it’s a beloved household pet, a racing horse, or an exotic avian, veterinarians must factor in various elements, from fur type to the thickness and color of the skin, to achieve optimal results.
For our four-legged friends, LLLT is used for a multitude of conditions, including arthritis, otitis, and post-operative care. It’s an ideal therapy for animals that may struggle with conventional treatments due to age or underlying health issues, providing a gentle yet effective form of relief.
For larger animals like horses, the benefits of laser therapy extend to the treatment of tendon and ligament injuries, as well as chronic conditions like laminitis. In these instances, LLLT can be incorporated into a broader healthcare regimen that addresses the unique demands of equine healthcare.
Even our more exotic patients can reap the rewards of laser therapy. Whether treating reptiles for skin lesions, managing pain in small rodents, or aiding neurological rehabilitation in birds, the versatility of LLLT allows veterinarians to customize treatment plans that cater to the needs of these special patients.
Erchonia is at the forefront of LLLT technology, providing veterinarians with the tools they need to advance their practice and improve the lives of the animals they serve. Through the application of innovative lasers specifically designed for veterinary use, Erchonia is supporting the growth of this field and expanding the horizon of veterinary care.
With a focus on consistent research and development, Erchonia’s vet lasers are trusted for their safety, efficacy, and ease of use. The goal is to enable veterinarians to offer the best possible care that aligns with the healing philosophy at the heart of the profession.
The potential for LLLT to continue reshaping veterinary medicine is vast, with new applications and insights emerging regularly. Through ongoing education and the cultivation of a supportive network, veterinarians can stay at the cutting edge of this promising modality, ensuring that the animals in their care benefit from the full spectrum of possibilities that laser therapy provides.
Veterinary laser therapy has transcended novelty to become an indispensable part of comprehensive animal health care. These innovations from Erchonia are not just about treating illnesses — they’re about enhancing the quality of life for the entire spectrum of creatures that share our world. By embracing the principles of low-level laser therapy, veterinarians are not only providing advanced care, but are also forging a healthier and more vibrant future for animal wellness.
The realm of laser therapy can be a labyrinth of bewildering terminology, often diverging from its conventional meanings. This confusion stems from a lack of comprehension among many companies, who merely echo past statements without genuine understanding. Yet, amidst this perplexity, Erchonia® stands as a beacon of clarity and commitment.
If you’ve encountered the name Erchonia®, we hope one consistent theme would resonate: our unyielding dedication to comprehending laser therapy through the most stringent clinical research standards and our steadfast faith in low-level laser therapy. Unlike conventional enterprises, Erchonia® wasn’t born from a calculated marketing strategy to peddle a product. Instead, it arose from an imperative—to further explore and develop a technology that alleviated our founder’s father from pain. Our mission remains rooted in spreading this transformative technology far and wide, aiding those grappling with similar afflictions, and enlightening healthcare providers on the significance of low-level lasers.
At Erchonia®, we recognize this pervasive confusion and are committed to illuminating the path forward. The distinction between “Power” and “Energy” in laser therapy serves as a prime example of this complexity. While these terms are often used interchangeably, their meanings carry distinct significance, influencing the effectiveness and safety of laser treatments. Let us delve deeper into this critical distinction, shedding light on its implications for practitioners and patients alike.
Ah, yes, the ubiquitous term in laser therapy discussions—power. We’ve all heard the comparisons: “100 times more powerful” or “10 times more potent.” But let’s break it down: power is essentially the number of photons a laser emits every second. Sounds impressive, right? But here’s the kicker: most of these conversations miss the mark on what power truly means and how less than crucial it is in laser therapy. To put it into perspective, imagine a laser operating at a wavelength of 630 nm and a power output of 5 mW. Now, let’s crunch some numbers to figure out how many photons this laser churns out every second. Using fundamental physics formulas, we determine that approximately 1.597×10^16 photons are emitted by the laser per second. That’s billions upon billions of photons buzzing around in just one second!
But here’s where it gets interesting: ramping up the power of a laser doesn’t necessarily mean better results. Why? Because no matter how impressive the photon count sounds, if the energy of those photons is too low to initiate the photochemical reaction, it’s all for naught. In essence, it’s not about “more power.” It’s about understanding the true essence of power in laser therapy—how it interacts with the body’s biology and quantum physics principles. After all, it only takes one photon to kickstart the photochemical reaction, rendering the notion of “more power” obsolete.
So, the next time you hear the term “power” thrown around in laser therapy discussions, remember it’s not about quantity, but quality. It’s about harnessing the right amount of energy, not power to ignite the healing process within the body—a concept that Erchonia® champions wholeheartedly.
Now, let’s talk about electron volts—a term that sounds like it belongs in a science fiction novel, but it’s actually a key player in the world of atomic and nuclear physics. Essentially, an electron volt (eV) is the amount of energy gained by an electron when it’s zipping through an electric potential difference—kind of like a roller coaster ride for electrons. Picture this: each electron gets a boost of energy as it accelerates from “rest” to “excited,” thanks to this electric potential difference.
But why does this matter? Well, this electrifying journey is what stimulates our cells and triggers that magical photochemical response we’re all after. In other words, it’s the spark that ignites the healing process within our bodies. So, while it may sound like something straight out of a sci-fi flick, electron volts are actually the unsung heroes of laser therapy, quietly powering the transformative effects we’ve come to rely on. And when it comes to understanding the science behind laser therapy, knowing the role of electron volts is like unlocking the secret to its success.
And here’s where Erchonia® steps in with a game-changer: multiple wavelength lasers. Each wavelength boasts its own unique electron volt (eV) output, and only precise matches of energy will kickstart those vital protein complexes within the mitochondria. We’re talking about the Electron Transport Chain (ETC), the powerhouse where all the magic of laser therapy unfolds. And guess what? It’s got nothing to do with power and everything to do with energy.
So, whether it’s understanding the intricate dance between wavelengths or unraveling the mysteries of electron volts, Erchonia® is committed to illuminating the path forward in laser therapy—because when it comes to healing, every detail matters.
More than half of Americans want to lose weight, but the options for doing so are generally limited. Most diets fail, while surgical interventions like liposuction and lipectomies are invasive, expensive, and risky. Increasingly, though, non-invasive procedures for fat loss are available. Green wavelength treatment, which uses an externally applied laser to shrink a patient’s BMI, is one such option for safe and effective fat cell removal.
Green wavelength treatment is an exciting option for patients who want to lose fat quickly, safely, and comfortably. In simplest terms, it uses a low-level laser, or “cold” laser, to empty fat cells without destroying them. The mechanism is as follows: FDA-approved lasers penetrate the walls of the adipocytes—the formal name for the cells that store fat—through a process called photobiomodulation. While lasers vary, Erchonia’s Emerald Laser has ten 520-542 nanometer green laser diodes that stimulate the fat loss process.
When lasers are applied to the area in question, they create tiny pores or openings on the fat cell walls. This is important because the laser also emulsifies the fat inside the cell. The pores created by the laser serve as an exit door, allowing the emulsified fat to leave the cell. Emptying fat cells is preferred to procedures that fully destroy fat cells, as techniques that destroy fat cells often cause unintended weight gain in other areas of the body. Emptying fat cells also preserves them for future use.
The mechanism behind green wavelength treatment is effective and safe. According to peer-reviewed research, 80% of fat is released from adipocytes after four minutes of laser exposure, while that figure jumps to 99% after six minutes. Thus, fat cell survival after green wavelength treatment is extremely low—which is desirable. Once the fat is released, the body can naturally dispose of it through the lymphatic system.
Low levels of fat cell survival after green wavelength treatment are demonstrated in the shrinking circumference of targeted areas as well. In one study, adults treated with low-level laser therapy for fat cell removal lost at least 2 cm—a statistically significant result—around their waists in just four weeks. In another study, participants lost an average of 3 inches across their waist, hips, and thighs after just two weeks of treatment with low-level lasers. Meanwhile, Erchonia’s Emerald laser has been shown to stimulate up to 6 inches of fat loss after just two weeks.
Choosing green wavelength treatment for fat cell removal has many benefits for patients beyond the fat loss itself. As mentioned, the fat loss mechanism behind this approach is gradual and non-invasive. This makes it safer than many alternatives. There’s no heat, anesthesia, incisions, bruising, or swelling with green wavelength treatment. Patients simply lie on a comfortable table, where the green lasers can be applied to various areas with unwanted fat. Each session typically lasts just 30 minutes.
The process is painless for patients—local anesthesia isn’t even required. As a result, this type of treatment doesn’t interfere with a patient’s day-to-day life. Surgical options for fat loss tend to have longer recoveries and may also result in scarring or other undesired side effects. With cold lasers, patients can continue daily activities immediately after treatment, making the approach both efficient and effective.
Using low-level lasers for fat loss is also an extremely precise option. Whether patients want to lose fat on their waist, thighs, hips, or arms, the treatment can be targeted to the exact area of concern. On top of that, when fat exits the cells, it generally releases endorphins—sometimes referred to as the body’s natural painkillers. Thus, patients may enjoy mood enhancements from the procedure as well.
Fat loss is a top priority for countless Americans. While fat loss can be extremely challenging, it doesn’t have to be. Green wavelength treatment is an extremely innovative and targeted way to stimulate fat loss using FDA-approved lasers. While it may seem complicated, the science behind green wavelength therapy is actually quite straightforward, with lasers creating tiny holes that allow fat to exit the cells in question.
Cryolipolysis and lipectomies are far riskier techniques for fat cell removal and require far longer recovery times. Low-level lasers, meanwhile, cause no pain or discomfort and effectively remove fat in a short amount of time. Already, many people have enjoyed this approach to fat loss. But as more people understand the science behind how fat cells respond to green wavelength treatment, the procedure is sure to grow in popularity even more.
Cold laser therapy—also known as Low-Level Laser Therapy (LLLT) or Photobiomodulation (PBM)—can be used to treat a long list of ailments, including arthritis, fibromyalgia, carpal tunnel, plantar fasciitis, muscle sprains, back pain, and skin conditions. With this innovative and painless treatment, low-intensity lasers are applied to the injured area, lowering inflammation, improving blood flow, and stimulating tissue regeneration in the process.
Patients who are new to this modality often have a lot of questions about it—and the first is usually with regard to laser therapy cost. Let’s take a look at what new patients need to know about the expenses involved in cold laser therapy.
Calculating the cost of laser therapy is difficult, because treatment plans vary. A single session of cold laser therapy is relatively quick, lasting anywhere from 60 seconds to 10 minutes. The length of time will depend on the placement and severity of the problem. The amount that clinics charge for a single session also varies. Generally, the cost of cold laser therapy ranges from $50 to $150 per session, as treatment does require advanced technology and expertise.
In addition to clinics charging different amounts for a single session, the number of sessions a patient needs will also vary. Some conditions can be resolved in as few as one to three sessions. Others require as many as thirty. For a patient who only needs three sessions, LLLT could cost as little as $150 total. But for patients requiring a dozen sessions at a higher individual price tag, cold laser therapy could cost close to $2000.
Naturally, cold laser therapy is far more affordable when health insurance covers the treatment. As things currently stand, Medicare does not cover cold laser therapy, but some private insurers do. As the benefits of cold laser therapy continue to be demonstrated in practice, more insurance providers are opting to cover the treatment for patients. Patients should ask their medical provider if they bill insurance for treatment, in addition to contacting their insurance provider directly to see if LLLT is covered as part of their plan.
Laser therapy cost should not be a hindrance to patients who want to try this innovative and effective treatment. It’s also worth noting that the cost of cold laser therapy should be compared to other suggested treatments. Alternatives like surgery tend to be far more expensive, while also requiring a longer recovery period. One study about LLLT noted that it improves the quality of life for patients at “a fraction of the cost” of incumbent approaches.
Because cold laser therapy is non-invasive and effective, most providers are willing to work with patients to find a payment option that suits their needs. They want as many people to reap the benefits of LLLT as possible. For patients who struggle to pay out of pocket for cold laser therapy, a payment plan can be created, allowing the cost to be spread out over a longer period of time. Some providers also offer treatment bundles or upfront discounts. Once again, patients should talk to their provider directly if they are concerned about cost. It can also be helpful to speak to several providers so payment plans can be compared before treatment is started.
The price tag of cold laser therapy is not necessarily reflective of its true value. There are many latent benefits to choosing this treatment option, including the fact that patients are not required to pay for pharmaceutical treatment on an ongoing basis. As already mentioned, cold laser therapy may also prevent the need for surgery, meaning patients won’t have to deal with the lost earnings that accompany a slow and painful recovery from an incision. When considering the cost of LLLT, patients should also consider the fact that the treatment is highly targeted and speeds up the healing process.
Cold laser therapy is a very promising treatment option for patients experiencing a wide range of conditions. Because the treatment is relatively new, cost can vary depending on insurance, the provider, the treatment plans they offer, and the area that is being treated. In most cases, though, providers are quite willing to work with patients to find a treatment plan that works for the situation at-hand. While cost can be a legitimate concern, the demonstrated benefits of cold laser therapy tend to offset them.
Altogether, LLLT is fast, effective, and painless, allowing patients to get back on their feet and back to their lives quickly. That’s priceless.
In today’s rapidly advancing medical field, innovative technologies continue to revolutionize patient care and treatment outcomes. One such technology that has gained significant attention and proven effectiveness is green wavelength low-level laser therapy. In this article, we will explore the benefits, applications, and implementation of green wavelength lasers in medical practice.
Low-level laser therapy (LLLT) utilizes light wavelengths to stimulate cellular processes and promote healing. Green wavelength lasers, specifically, have gained popularity due to their unique properties and therapeutic benefits. Let’s delve into what sets them apart and how they can enhance patient care.
Green wavelength lasers operate within a specific frequency range, typically between 510 and 570 nanometers. This range offers distinct advantages over other types of lasers. Green lasers penetrate tissue more effectively, allowing for deeper tissue reach and improved targeting of specific areas. They are also well-absorbed by blood, making them ideal for circulatory-related conditions.
Compared to other lasers, green wavelength lasers emit a lower level of thermal energy, reducing the risk of thermal damage or discomfort for patients. This makes them safer and more tolerable across various patient populations.
Green wavelength low-level lasers find applications across a range of medical fields, including but not limited to dermatology, physical therapy, chiropractic care, and sports medicine. Their versatility allows for the treatment of chronic pain, musculoskeletal injuries, wound healing, and dermatological conditions – as well as targeted fat loss.
For instance, patients with arthritis can benefit from green wavelength laser therapy as it helps improve range of motion, decrease pain and inflammation, and promote tissue regeneration. In dermatology, green wavelength lasers effectively target vascular and pigmented lesions, making them valuable tools for treating conditions like rosacea, spider veins, and melasma.
Integrating green wavelength laser technology into your practice requires careful consideration and planning. Here are some steps to guide you through the implementation process:
Implementing green wavelength low-level laser technology can provide numerous benefits for both patients and practitioners.
For patients:
For practitioners:
Green wavelength low-level laser technology offers immense potential for enhancing patient care and treatment outcomes. By implementing this innovative therapy into your practice, you can revolutionize the way you approach various conditions and optimize patient outcomes.
Remember, each patient is unique, and treatment plans should be tailored to individual needs. As you embark on this journey, continue to stay updated with the latest research and advancements in green wavelength laser therapy. Embrace the possibilities, explore the benefits, and open new doors to improved patient care through the integration of green wavelength low-level laser technology.
To learn more about green wavelength low-level laser devices and their benefits, explore full product descriptions, treatments, and specifications of our new GVL Laser and Emerald Laser. Embrace the power of green wavelength lasers and elevate your practice’s potential for exceptional patient care and treatment outcomes.
Hold the phone, wellness warriors. Before you jump on the latest red light therapy trend with those flashy LED panels, let’s talk science, baby. Because in the world of light therapy, not all devices are created equal. In fact, most of them are a sham.
Yes, you read that right. While LEDs are all the rage on Instagram and social media, they simply don’t hold a candle to the effectiveness of Erchonia® lasers, the undisputed champion in low-level laser therapy (LLLT).
Don’t be fooled by the hype. Let’s dive deep and expose the truth about red light therapy LEDs and why they’re nothing more than a fad in the face of Erchonia’s® laser technology.
Several studies support the notion that lasers outperform LEDs in LLLT applications. For example, a study published in the journal Photomedicine and Laser Therapy found that laser treatment significantly improved wound healing compared to LED therapy. Similarly, another study published in the Journal of the American Podiatric Medical Association demonstrated that laser therapy was more effective than LED therapy in reducing pain and inflammation associated with plantar fasciitis.
27 Years of Research and Innovation: Erchonia, however, is a different story. We’ve been at the forefront of LLLT research and development for over 27 years. Our lasers are backed by extensive level 1 clinical research and studies, demonstrating their efficacy for a wide range of conditions, these studies are also conducted by using LEDs as the sham device to prove the efficacy of laser vs led and after 27 years of research; Laser is still superior.
A 2020 study published in the Orthopedics and Rheumatology Open Access Journal revealed the impressive potential of Erchonia lasers in pain reduction. The study compared the effectiveness of Erchonia laser therapy to a sham treatment (LEDs) in patients with chronic neck pain.
These findings demonstrate the superiority of Erchonia lasers compared to LEDs in managing chronic neck pain. They offer significant pain reduction, long-term relief, and sustained improvement, making them a promising option for individuals seeking effective pain management solutions.
If you’re looking for a light therapy solution that’s backed by science and proven to deliver results, don’t waste your time with red light therapy LEDs. Choose Erchonia lasers – the gold standard in LLLT technology.
Don’t fall for the LED sham. Invest in your health and well-being with Erchonia lasers, the only choice for serious results.
Ready to experience the power of Erchonia lasers? Find a certified provider near you today and start your journey to better health!
P.S. Share this article with your friends and family so they can also learn the truth about LEDs and lasers!
For millennia, humans have harnessed the power of sunlight, recognizing its ability to promote growth, healing, and well-being. However, with the rise of technology, artificial light sources have emerged, promising similar benefits. While both coherent and incoherent light sources can emit the same wavelength, their impact on the body at the cellular level is demonstrably different. Understanding these intricacies is crucial for optimizing the therapeutic potential of light therapy.
The human body is a complex orchestra, where cells communicate through a symphony of signals, including biophotons – low-level light emitted by cells themselves. These biophotons play a vital role in regulating various cellular processes, including:
This intricate network of biophoton communication is finely tuned to respond to specific wavelengths of light. Coherent light, with its synchronized photons, offers unique advantages in this regard:
In contrast, the incoherent nature of light emitted by LEDs results in:
Beyond communication, light also plays a crucial role in the body’s natural healing processes. When injury or disease occurs, specific cells are activated to initiate the repair cascade. Coherent light, once again, offers distinct advantages:
In contrast, incoherent light often exhibits diminished effects:
The body’s intricate communication and healing processes rely heavily on the precise interaction with light. Coherent light, with its synchronized photons, offers unique advantages over incoherent light in terms of:
As research continues to explore the therapeutic potential of light, understanding the key differences between coherent and incoherent light will be essential for developing effective and targeted light therapy solutions. This knowledge empowers individuals to make informed choices about their health and well-being, harnessing the power of light for optimal healing and regeneration.
If you’re looking for a light therapy solution that’s backed by science and proven to deliver results, don’t waste your time with red light therapy LEDs. Choose Erchonia lasers – the gold standard in LLLT technology.
P.S. Share this article with your friends and family so they can also learn the truth about LEDs and lasers!
References
Coming to you from SCBIO’s 2023 annual conference, Matthew and Heather welcome Steve and John Shanks of Erchonia, a world-leading company in the field of lower-level laser technology. They discuss the exciting news of their company’s relocation to South Carolina and share insights about Erchonia’s innovative work – tune in now!
Heather Hoopes-Matthews: Hey everyone welcome to Taking The Pulse, A Healthcare and Life Sciences video podcast. I am Heather Hoopes-Matthews coming to you from SC BIOS 2023 Annual Conference in Charleston, South Carolina. This is really one of the southeast, Premier Life Sciences events pulling together some of the leading innovators in the industry. Matthew we’re excited today to welcome to soon to be South Carolina residents Steve and John Shanks with Erchonia. Today on the stage this morning you announced your company is coming to South Carolina, you’re a global leader with low level laser technology. Steve, start us off. Tell us a little bit about your company and its mission.
Steven Shanks: Erchonia, our tagline is the world leader in low level laser therapy. So we try to prove that through research and development. So we build our own products, and we do our own clinical trials, obviously working with physicians, and from there we go to the FDA to try to get marketing licenses. And up to this point, we’ve probably got about 21 different indications to the FDA. Wow. That’s impressive.
Matthew Roberts: So you guys have been located in Florida and you made the decision thankfully to move to South Carolina and Greenville tell us a little bit about what went into that decision. How did you pick South Carolina?
John Shanks: You know, we’re really fortunate, we can pretty much go anywhere, we don’t need a particular storefront we sell nationally and internationally. So really, with our first approach was what was going to work best for the quality of life for our family. And after, you know, looking around, and a number of places in the country, um, it came down to a couple of cities. And you know, when we finally all sat down and said, Alright, let’s dial in on one and we got everybody out to Greenville, it became a really easy choice. I mean, there were just there’s a number of factors, that it made it clear that Greenville was just going to work really well for us, as a family and as a business. So that’s what we did. And that’s how we’re here. And then it took about two months for us to find property and start to go okay, let’s, let’s start building and get things done. Make it real. So then we started moving quick.
Heather Hoopes-Matthews: Yeah. And you said that, before we started, you mentioned you poured a slab already.
John Shanks: We did we did you know what’s amazing with because they had all that rain over the last couple of weeks. They actually had to get those guys out there like 2am, about three weeks ago, to get the slab poured. I mean, they had the foundations of footings and poured for a little while but not yeah, now that that piece is underway, everything should start moving pretty quickly.
Matthew Roberts: So tell us a little bit about what you need in terms of have this laser technology? What kind of facility do you need? Is it need a lot of space? Or is there anything special that you have to put in place?
John Shanks: You know, for us, because we actually have a full machine shop and everything because we make everything internally I mean, you know, we take raw metal and turn them into all of the components. So for us the biggest factor out there will be the things that relate to things electrical, because we have to run some pretty large machines out there. Um, so for us, that’s about the only thing that is particularly noteworthy about it. Right, the rest of it, we like it to be DNO kind of artsy and cool just because we get to work there every day. So we spent a little money on the architecture and everything else, it should be a really neat looking building by the time we’re done. But, um, yeah, we’re about to about 20% bigger than the facility that we just expanded in Florida. And we’re, you know, we’re, we’ve purchased enough land that we can purchase, we can do about another, another 40% On top of that total square footage. So you know, we’re saving that for future growth. So we’re trying to be a little forward looking that way. It’s good to hear.
Steven Shanks: A little bit different than everybody else. Were with us since we are a family business. We’re looking to bring we keep everything in house. So we’re not looking to farm stuff off and have it manufactured somewhere else. Right. So we’re employed.
Matthew Roberts: So everything is built there and shipped from there to the customer?
John Shanks: Yeah, we literally ship internationally from the from the from that single location. Yeah, great. Great.
Heather Hoopes-Matthews: What kind of role if any, did SC bio play in your decision?
John Shanks: You know, for us? Obviously, having a, you know, a bit of a robust life sciences industry is always is noteworthy. Because when people say oh, hey, you’re there, people kind of consider from our standpoint. Truly, though, for us, what it finally got us here was it was just the whole environment, the city itself. So I mean, we count that as an added bonus, I guess, for lack of a better expression. Right. I mean, I think that’s kind of our take on it. Yes.
Heather Hoopes-Matthews: Well, it’s good to have you add to the volume that’s been increasing here in the state because the life sciences industry has been increasing at this pace above everybody, right.
Matthew Roberts: And just another example of of the life science industry, benefiting from the state. It’s everything about it, plus its pro business stance. Just another example of why South Carolina is leading the nation.
John Shanks: You know, that is one thing we did find out the state itself actually has worked very favorably with us. One of the other cities we’re looking at, which will remain nameless for the moment but it was in North Carolina. Yeah, we found working with with those people was much more clear. On a friendly eye, we got sensitive South Carolina wanted us here. Great me as much as we wanted to be here. So we do I think that was Yeah, well, yeah, that was that was very much.
Matthew Roberts: Well, the people at Department of Commerce will be glad to hear that.
Steven Shanks: Yeah, they did a good job.
Heather Hoopes-Matthews: Well, speaking of jobs, tell us about the jobs. Well, all of your jobs moved from, from Florida here.
Steven Shanks: Luckily, because we are a family business, a lot of our people will come, most of them would have.
John Shanks: You know, we had 53, down there 51 of which are coming up. Oh, wow. The longevity of our employees. I mean, you know, we we have sales reps that have been with us for 1618 years, right. So, but yeah, 51 jobs will be coming up, I think we have an average salary, that’s a little over $90,000. So we expect from further growth, probably within the next couple of years, we’ll probably have to hire eight or 10 more people in, in relative fashion. And then we’re introducing a number of new products over the next couple of years. So we have to really feel like that’s why we’re holding that other percentage of land to we got to see how that how that builds out for.
Matthew Roberts: And how do you do research and development for future products?
Steven Shanks: So for instance, we just had a conference call Monday with the FDA. So we’re looking do a clinical trial on autism. So we’ve done a pilot study. So we submit our protocol to the FDA, the FDA said, Okay, this is what you need. So after this, we’ll finish writing up the protocol, send it off to an IRB, line up our researchers start a research. And then if the data is good, we submit it back to the FDA, we get a 510 K, which is a marketing license from the FDA, and then we’ll market the product.
Matthew Roberts: So you mostly use CROs to do your research, or how do you how do you do the clinical research?
Steven Shanks: Most of the research we wanted out of our business. But for instance, one of the gentlemen that we’re using is a neurologist up in Boston. So another is a research institute in Phoenix. So but we do research, we go to University of Illinois, Chicago, we’re doing some stuff at Mayo Clinic. So we do research pretty much all over the world. But we try to keep most of it focused in the US.
Matthew Roberts: And one of the things that’s interesting about South Carolina is we’ve got these great research, facilities, universities, you know, University of South Carolina, Clemson. Clemson would be essentially right in your backyard.
Steven Shanks: So we met the lady from Clemson. So yeah, that’s good.
Matthew Roberts: Because that’s that’s what this is all about making those connections.
Heather Hoopes-Matthews: John and Steve, welcome to South Carolina.
John Shanks: Thank you very much. Yeah, we’re really looking forward to get into the process finished up and getting the move on. Yeah.
Heather Hoopes-Matthews: We look forward to hearing about your groundbreaking in the fall. And, you know, your vision for the future.
Matthew Roberts: We want you guys to come back after you, you know, get built out so you can show us some pictures? Yes.
John Shanks: Um, at some point, I’m guessing probably right around November, we’ll have a full on open house. And we were planning on inviting as many people as want to come see it, I think in the building. I think it’ll be impressive. I think I’ll leave it at that.
Heather Hoopes-Matthews: It will be your family owned and you’ve got control. Well, it’s exciting to hear your good news. And it’s a blessing for our state. For those of you who joined us today, we hope you learned a little bit about new companies coming to South Carolina and what the Shanks family does, and we look forward to seeing you next time right here on Taking The Pulse Healthcare and Life Sciences Podcast.
Erchonia Corp., a laser technology manufacturer, will invest $6.7 million to relocate its corporate headquarters from Melbourne, Florida to Fountain Inn.
The investment is expected to create 51 jobs at the company’s facility in South Chase Industrial Park, which is expected to be operational by October 2023.
“We are looking forward to the completion of our state-of-the-art facility that is being built to our exact specifications,” said Erchonia Corp. President Steven Shanks. “As the location of Erchonia’s new corporate headquarters, Greenville County is centrally located and is ideal for Erchonia’s planned growth and expansion as a world leader in low-level laser technology.”
For more information, visit erchonia.com.
